Skip to main content
. 2016 Dec 30;427(1):177–185. doi: 10.1007/s11010-016-2909-5

Fig. 1.

Fig. 1

Migratory ability of gliomas-CM treated SFMSCs in vitro. a Three types of MSCs showed changing migratory abilities in response to each CM. b Migratory abilities of SFMSCs treated with gliomas-CM were normalized and significantly enhanced relative to SFM. Data are expressed as the mean ± SD, *P < 0.05